1. Home
  2. DNLI vs PATK Comparison

DNLI vs PATK Comparison

Compare DNLI & PATK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • PATK
  • Stock Information
  • Founded
  • DNLI 2013
  • PATK 1959
  • Country
  • DNLI United States
  • PATK United States
  • Employees
  • DNLI N/A
  • PATK N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • PATK Auto Parts:O.E.M.
  • Sector
  • DNLI Health Care
  • PATK Consumer Discretionary
  • Exchange
  • DNLI Nasdaq
  • PATK Nasdaq
  • Market Cap
  • DNLI 3.1B
  • PATK 3.2B
  • IPO Year
  • DNLI 2017
  • PATK N/A
  • Fundamental
  • Price
  • DNLI $20.73
  • PATK $90.18
  • Analyst Decision
  • DNLI Strong Buy
  • PATK Strong Buy
  • Analyst Count
  • DNLI 13
  • PATK 9
  • Target Price
  • DNLI $37.91
  • PATK $102.07
  • AVG Volume (30 Days)
  • DNLI 814.8K
  • PATK 361.5K
  • Earning Date
  • DNLI 03-04-2025
  • PATK 02-06-2025
  • Dividend Yield
  • DNLI N/A
  • PATK 2.13%
  • EPS Growth
  • DNLI N/A
  • PATK N/A
  • EPS
  • DNLI N/A
  • PATK 4.11
  • Revenue
  • DNLI N/A
  • PATK $3,715,683,000.00
  • Revenue This Year
  • DNLI N/A
  • PATK $8.30
  • Revenue Next Year
  • DNLI $289.18
  • PATK $6.51
  • P/E Ratio
  • DNLI N/A
  • PATK $21.90
  • Revenue Growth
  • DNLI 204.74
  • PATK 7.14
  • 52 Week Low
  • DNLI $14.56
  • PATK $67.72
  • 52 Week High
  • DNLI $33.33
  • PATK $98.90
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 42.56
  • PATK 41.41
  • Support Level
  • DNLI $21.33
  • PATK $90.85
  • Resistance Level
  • DNLI $22.81
  • PATK $96.51
  • Average True Range (ATR)
  • DNLI 1.27
  • PATK 2.72
  • MACD
  • DNLI -0.10
  • PATK -0.74
  • Stochastic Oscillator
  • DNLI 15.83
  • PATK 3.66

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

Share on Social Networks: